Artificial Intelligence and Deep Learning in Ophthalmology: A 21st Century Gold Rush
Can't see this email? View it online
   
  October 29, 2018  
  Artificial Intelligence in Healthcare  
  The latest artificial intelligence in healthcare news from News Medical  
 

#ALT# Artificial Intelligence and Deep Learning in Ophthalmology: A 21st Century Gold Rush

These days, it is clear that we are living in the dawn of the age of machines; with driverless cars and AI Doctors. In 2011, a comprehensive package of cognitive healthcare solutions applying health data, machine learning and cloud analytics (so called “precision medicine”) was introduced by IBM Watson (International Business Machines Corporation, NYK, USA).

Read More
 
   AI could be used to diagnose Alzheimer's years before symptoms appearAI could be used to diagnose Alzheimer's years before symptoms appear
 
An Artificial Intelligence (AI) algorithm has been trained to pick up early signs of cognitive decline, which could result in Alzheimer’s disease (AD).
 
   New method based on artificial intelligence may help predict epilepsy outcomesNew method based on artificial intelligence may help predict epilepsy outcomes
 
Medical University of South Carolina neurologists have developed a new method based on artificial intelligence that may eventually help both patients and doctors weigh the pros and cons of using brain surgery to treat debilitating seizures caused by epilepsy.
 
 Artificial Intelligence and Life Science
 
Artificial Intelligence and Life ScienceArtificial intelligence, or AI, constitutes machine learning and deep learning, which enables computers to learn without being explicitly programmed every step of the way. This type of technology has shown to be very useful in life science industries, such as by sorting different types of cancer cells in laboratories.
 
 
 Machine Learning in Drug Development
 
Machine Learning in Drug DevelopmentDrug development is a costly and often fruitless process. Many of the drugs initially investigated are not brought to clinical trial, and many after that are not approved by the FDA or other similar boards.
 
 
 AI approach could identify nuanced imaging features specific for recalled-benign mammograms
 
AI approach could identify nuanced imaging features specific for recalled-benign mammogramsAn artificial intelligence approach based on deep learning convolutional neural network could identify nuanced mammographic imaging features specific for recalled but benign (false-positive) mammograms and distinguish such mammograms from those identified as malignant or negative.
 
 
 Artificial Intelligence and Deep Learning in Medicine
 
Artificial Intelligence and Deep Learning in MedicineArtificial intelligence, or AI, is an umbrella term for machine learning and deep learning. It is where a machine takes in information from its surroundings and, from that, makes the most optimal decision appropriate to the situation.